NCT01146782

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

The ATLAST Trial - A Multicenter, Prospective Study of the Attune Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 367 (actual)
• Sponsor: ApniCure, Inc. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea. The objective of the study is to demonstrate safety and effectiveness of the Attune Sleep Apnea System to support FDA marketing clearance of the device.

Conditions

• Obstructive Sleep Apnea

Interventions

Type	Name	Description
DEVICE	Attune Sleep Apnea System	Console and mouthpiece sleep apnea system

Timeline

• Start date: 2010-06-01
• Primary completion: 2012-03-01
• Completion: 2012-03-01
• First posted: 2010-06-22
• Last updated: 2014-06-30
• Results posted: 2014-06-30

Locations

6 sites across 1 country: United States